The Latin America, Middle East and Africa Bionic Eye Market is expected to witness market growth of 14.8% CAGR during the forecast period (2020-2026).
The bionic eye market is driven globally due to the rising number of patients suffering from complete or partial blindness. Moreover, increasing problems of eye-related to aging is another major factor leading to the growth of the market. According to a report by the WHO, nearly 250 million people above 50 years of age are visually damaged. More than 80% of people in the developing countries are suffering from problems related to eyesight, and due to financial conditions, almost 50% of people are not able to have a proper treatment.
Bionics is also referred to as biomedical implants that are artificial devices added to the body. The artificial implants restore the normal functioning of the lost or non-functional body parts. The rise in the geriatric population, an increase in the number of patients suffering from chronic diseases, and the government’s attention to funding R&D initiatives are likely to drive the growth of the market. Though, the high cost of the bionic devices and treatment is expensive in addition to its stringent approval process for such devices that are anticipated to hinder the market growth.
Based on Technology, the market is segmented into Electronic and Mechanical. Based on End Use, the market is segmented into Hospitals, Eye Clinics and Other End uses. Based on Type, the market is segmented into Implanted Eye and External Eye. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Second Sight Medical Products, Inc., Pixium Vision S.A., Nidek Co., Ltd., Optobionics Corporation, Biomedical Technologies S.L., Bionic Vision Technologies Pty. Ltd., Monash Vision Group, The Bionic Eye (The Bionic Group), Nano Retina Ltd. and iBionics.
Scope of the Study
Market Segmentation:
By Technology
By End Use
By Type
By Country
Companies Profiled
Unique Offerings from the Publisher
The bionic eye market is driven globally due to the rising number of patients suffering from complete or partial blindness. Moreover, increasing problems of eye-related to aging is another major factor leading to the growth of the market. According to a report by the WHO, nearly 250 million people above 50 years of age are visually damaged. More than 80% of people in the developing countries are suffering from problems related to eyesight, and due to financial conditions, almost 50% of people are not able to have a proper treatment.
Bionics is also referred to as biomedical implants that are artificial devices added to the body. The artificial implants restore the normal functioning of the lost or non-functional body parts. The rise in the geriatric population, an increase in the number of patients suffering from chronic diseases, and the government’s attention to funding R&D initiatives are likely to drive the growth of the market. Though, the high cost of the bionic devices and treatment is expensive in addition to its stringent approval process for such devices that are anticipated to hinder the market growth.
Based on Technology, the market is segmented into Electronic and Mechanical. Based on End Use, the market is segmented into Hospitals, Eye Clinics and Other End uses. Based on Type, the market is segmented into Implanted Eye and External Eye. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Second Sight Medical Products, Inc., Pixium Vision S.A., Nidek Co., Ltd., Optobionics Corporation, Biomedical Technologies S.L., Bionic Vision Technologies Pty. Ltd., Monash Vision Group, The Bionic Eye (The Bionic Group), Nano Retina Ltd. and iBionics.
Scope of the Study
Market Segmentation:
By Technology
- Electronic
- Mechanical
By End Use
- Hospitals
- Eye Clinics
- Other End uses
By Type
- Implanted Eye
- External Eye
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Second Sight Medical Products, Inc.
- Pixium Vision S.A.
- Nidek Co., Ltd.
- Optobionics Corporation
- Biomedical Technologies S.L.
- Bionic Vision Technologies Pty. Ltd.
- Monash Vision Group
- The Bionic Eye (The Bionic Group)
- Nano Retina Ltd.
- iBionics
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Bionic Eye Market by Technology
Chapter 4. LAMEA Bionic Eye Market by End-use
Chapter 5. LAMEA Bionic Eye Market by Type
Chapter 6. LAMEA Bionic Eye Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Second Sight Medical Products, Inc.
- Pixium Vision S.A.
- Nidek Co., Ltd.
- Optobionics Corporation
- Biomedical Technologies S.L.
- Bionic Vision Technologies Pty. Ltd.
- Monash Vision Group
- The Bionic Eye (The Bionic Group)
- Nano Retina Ltd.
- iBionics
Methodology
LOADING...
